Laurie Stelzer's Net Worth

$7.68 Million

Estimate Recalculated Nov 11, 2024 01:40PM EST

Who is Laurie Stelzer

Laurie Stelzer has an estimated net worth of $7.68 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, PMV Pharmaceuticals, Inc., HALOZYME THERAPEUTICS INC, Surface Oncology, Inc., Mirati Therapeutics, Inc., and Spyre Therapeutics, Inc..

SEC CIK

Laurie Stelzer's CIK is 0001644348

Past Insider Trading and Trends

2020 was Laurie Stelzer's most active year for acquiring shares with 9 total transactions. Laurie Stelzer's most active month to acquire stocks was the month of January. 2019 was Laurie Stelzer's most active year for disposing of shares, totalling 8 transactions. Laurie Stelzer's most active month to dispose stocks was the month of January. 2023 saw Laurie Stelzer paying a total of $824,989.00 for 166,117 shares, this is the most they've acquired in one year. In 2021 Laurie Stelzer cashed out on 33,289 shares for a total of $331,491.60, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ARENA PHARMACEUTICALS INC

EVP & Chief Financial Officer
Updated Mar 11, 2022
Form 4
-100.00%
-223.26K
Mar 11, 2022
Disposition
Mar 11
Form 4
144.00%
21.46K
Jan 05, 2022
36.37K
Grant
Jan 03
Form 4
-22.62%
-4.36K
$76.10
-$331.49K
Apr 02, 2021
14.90K
Options
Mar 16
Form 4
60.71K
Mar 03, 2021
60.71K
Grant
Mar 01
Form 4
138.30K
Mar 17, 2020
138.30K
Grant
Mar 16
Form 3
Mar 17, 2020
Showing 6 results

PMV Pharmaceuticals, Inc.

Investor
Updated Jun 10, 2024
Form 4
67.50K
Jun 10, 2024
67.50K
Grant
Jun 06
Form 4
21.50K
Jun 12, 2023
21.50K
Grant
Jun 08
Form 4
-50.00%
-19.50K
Jun 06, 2022
19.50K
Grant
Jun 02
Form 4
-50.00%
-16.33K
Jun 09, 2021
16.33K
Grant
Jun 02
Form 3
Sep 24, 2020
Showing 5 results

HALOZYME THERAPEUTICS INC

SVP, Chief Financial Officer
Updated Feb 24, 2020
Form 4
-3.41%
-4.51K
$21.83
-$98.41K
Feb 24, 2020
137.56K
Options
Feb 22
Form 4
-2.12%
-2.70K
$21.10
-$56.97K
Feb 18, 2020
134.90K
Options
Feb 14
Form 4
-3.60%
-3.89K
$20.00
-$77.88K
Feb 13, 2020
114.17K
Options
Feb 12
Form 4
101.71K
Feb 12, 2020
101.71K
Grant
Feb 10
Form 4
-7.87%
-8.28K
$19.21
-$158.96K
Feb 04, 2020
106.81K
Options
Feb 03
Form 4
-3.99%
-3.41K
$15.73
-$53.61K
Jun 17, 2019
91.96K
Options
Jun 15
Form 4
-3.74%
-3.94K
$16.81
-$66.21K
Feb 22, 2019
111.28K
Options
Feb 22
Form 4
-2.78%
-2.70K
$16.54
-$44.66K
Feb 15, 2019
104.47K
Options
Feb 14
Form 4
130.97K
Feb 14, 2019
130.97K
Grant
Feb 12
Form 4
-8.54%
-8.32K
$16.12
-$134.07K
Feb 05, 2019
99.05K
Options
Feb 03
Form 4
-5.31%
-3.25K
$19.02
-$61.89K
Jun 18, 2018
68.01K
Options
Jun 15
Form 4
-4.60%
-3.94K
$19.28
-$75.94K
Feb 23, 2018
91.69K
Options
Feb 22
Form 4
86.01K
Feb 16, 2018
86.01K
Grant
Feb 14
Form 4
-8.74%
-8.27K
$18.37
-$151.83K
Feb 05, 2018
96.30K
Options
Feb 03
Form 4
-6.22%
-2.58K
$13.05
-$33.71K
Jun 16, 2017
48.95K
Options
Jun 15
Form 4
118.49K
Feb 24, 2017
118.49K
Grant
Feb 22
Form 4
-9.14%
-9.09K
$12.26
-$111.38K
Feb 06, 2017
100.27K
Options
Feb 03
Form 4
Jun 16, 2016
37.50K
Options
Jun 15
Form 4
197.08K
Feb 04, 2016
197.08K
Grant
Feb 03
Form 4/A
10.00K
$17.24
$172.38K
Aug 26, 2015
10.00K
Purchase
Aug 20
Form 4
10.00K
$17.24
$172.38K
Aug 24, 2015
10.00K
Purchase
Aug 20
Form 4
252.50K
Jun 16, 2015
252.50K
Grant
Jun 15
Form 3
Jun 16, 2015
Showing 23 results

Surface Oncology, Inc.

Investor
Updated Jun 10, 2022
Form 4
24.00K
Jun 10, 2022
24.00K
Grant
Jun 08
Form 4
17.70K
Jun 10, 2021
17.70K
Grant
Jun 08
Form 4
12.00K
Jun 12, 2020
12.00K
Grant
Jun 10
Form 4
12.10K
Jun 06, 2019
12.10K
Grant
Jun 05
Form 3
Apr 18, 2018
Showing 5 results

Mirati Therapeutics, Inc.

Chief Financial Officer
Updated Aug 10, 2023
Form 4
27.87%
22.30K
$37.00
$824.99K
Aug 10, 2023
102.31K
Grant
Aug 09
Form 4
-5.49%
-4.65K
$37.06
-$172.22K
Jun 02, 2023
80.02K
Sale
Jun 02
Form 4
125.13%
72.32K
Jan 24, 2023
130.12K
Grant
Jan 20
Form 4
148.96K
Jun 03, 2022
148.96K
Grant
Jun 01
Form 3
May 16, 2022
Showing 5 results

Spyre Therapeutics, Inc.

Investor
Updated May 16, 2024
Form 4
11.32K
May 16, 2024
11.32K
Grant
May 14
Form 4
50.00K
Nov 27, 2023
50.00K
Grant
Nov 22
Form 3
Nov 27, 2023
Showing 3 results